What does SNAP-8 stand for?

The SNAP refers to SNAP-25, a protein involved in the machinery by which neurotransmitter is released at the neuromuscular junction, and the 8 refers to the peptide being eight residues long. The cosmetic rationale for the ingredient invokes that protein, which is where the name comes from. It is a reference to a proposed mechanism rather than a chemical description.

How does SNAP-8 relate to Argireline?

SNAP-8 is a longer version of it. Argireline is a trade name for acetyl hexapeptide-8, a six-residue cosmetic peptide; SNAP-8 extends that sequence to eight residues and appears in cosmetic ingredient listings as acetyl octapeptide-3. They come from the same line of cosmetic formulation development and invoke the same proposed mechanism, so they are routinely compared with one another in that industry\u2019s literature.

Is SNAP-8 a research peptide?

Not in the usual sense, and this is the most useful thing to understand about it. It was developed as an ingredient for topical cosmetic formulation, not as a laboratory tool compound, and the published work around it is predominantly cosmetic science rather than biomedical research. It is sold alongside research peptides for commercial reasons rather than because it belongs to the same category.

The International Nomenclature of Cosmetic Ingredients, the standardised system used to list ingredients on cosmetic packaging. SNAP-8 appears in it as acetyl octapeptide-3. The existence of an INCI name is itself informative: it tells you the compound was brought to market as a cosmetic ingredient, which is a different regulatory pathway and a different evidence standard from either a medicine or a research reagent.

Is SNAP-8 a medicine?

No. It is not a medicine and holds no marketing authorisation as one. Cosmetic ingredients are regulated under cosmetics legislation rather than medicines legislation, and the evidence required for a cosmetic claim is substantially different from that required for a medicinal one. A compound with a cosmetic ingredient listing has not been through medicinal assessment.

No. We do not stock it and there is no Certificate of Analysis for it in our library. It is covered here mainly to clarify the category confusion, since it is persistently listed as a research peptide when it is a cosmetic formulation ingredient.

What is SNAP-8?

5 min read · Updated October 2026 · MY PEPTIDES Research Team

Key facts

SNAP-8 is an eight-residue peptide developed as an ingredient for topical cosmetic formulation, where it appears under International Nomenclature of Cosmetic Ingredients naming as acetyl octapeptide-3. It is an extension of the better-known hexapeptide marketed as Argireline, acetyl hexapeptide-8, with two further residues. The SNAP in the name refers to SNAP-25, a protein involved in the machinery of neurotransmitter release at the neuromuscular junction, which is the mechanism the cosmetic rationale invokes. This makes SNAP-8 unusual among compounds sold alongside research peptides: it was designed as a formulation ingredient for topical use rather than as a laboratory tool, and its literature is largely cosmetic-science rather than biomedical. It is not a medicine and holds no marketing authorisation. MY PEPTIDES does not stock it. General information for laboratory context only, not medical advice.

The short answer

SNAP-8 is a cosmetic ingredient, not a research compound. That is the single most useful thing to know about it, and it is the thing least often said where it is sold.

It is an eight-residue peptide, listed in cosmetic ingredient nomenclature as acetyl octapeptide-3, developed as an extension of the six-residue peptide marketed as Argireline. The SNAP in its name refers to SNAP-25, a protein in the neurotransmitter-release machinery at the neuromuscular junction, which is the mechanism the cosmetic rationale appeals to.

Why the category matters

Compounds reach the market through different routes, and the route determines what evidence exists behind them.

A medicine goes through regulatory assessment of safety and efficacy for a defined indication. A research reagent makes no claims at all beyond identity and purity; its documentation is analytical, and it is sold for laboratory use only. A cosmetic ingredient sits somewhere else again: regulated under cosmetics legislation, assessed for safety in topical use, and supported by claims held to a standard quite different from the medicinal one.

SNAP-8 took the cosmetic route. It has an International Nomenclature of Cosmetic Ingredients designation, acetyl octapeptide-3, which exists precisely because it was brought to market as a formulation ingredient for topical products. Its literature is accordingly cosmetic-science literature.

So when it appears in a catalogue of research peptides, the category has quietly shifted and the reader is likely to carry across expectations that do not apply. Someone assuming a biomedical research literature will not find much of one. Someone assuming medicinal assessment will not find any.

The Argireline lineage

Argireline is the trade name for acetyl hexapeptide-8, a six-residue cosmetic peptide that became widely used in topical formulation. SNAP-8 is the same idea with two more residues, and the two are routinely compared in the cosmetic literature on the basis that a longer peptide might perform differently in a formulation.

Both invoke the same proposed mechanism around SNAP-25 and neurotransmitter release. It is worth noting what that mechanism requires in order to be relevant topically: a peptide applied to the skin surface would need to reach the relevant tissue, and peptide penetration through intact skin is a genuinely contested area of cosmetic science rather than a settled one. That debate is the substance of the field's interest in these ingredients, and it is not resolved by the ingredient having a name that references the protein.

Analytical notes

An eight-residue acetylated peptide is straightforward to synthesise and characterise. The acetyl group on the N-terminus is a standard modification and shows up cleanly in analysis.

One practical point if you are comparing documentation across categories: purity conventions for cosmetic ingredients are not identical to those for research peptides, and the figure quoted may be arrived at differently. The questions in our guide on certificates of analysis still apply, but the answers are worth reading in the light of what the material was made for.

For a peptide we do supply that genuinely sits in the skin-research literature rather than the cosmetic-formulation one, see our guide on GHK-Cu — a useful contrast in how the two categories differ.

Where MY PEPTIDES stands

We do not stock SNAP-8. There is no Certificate of Analysis for it in our library and no product page for it on this site, and this guide is not an offer to supply it. What we do supply, and the documentation standard we hold it to, is set out in our guide on certificates of analysis.

The bottom line

SNAP-8 is an eight-residue cosmetic formulation ingredient, listed as acetyl octapeptide-3 and extended from Argireline, whose name references the SNAP-25 protein its proposed mechanism invokes. It is not a research compound and not a medicine, the topical penetration question behind it is unsettled, and we do not supply it.

All compounds referenced on this site are discussed strictly in the context of in-vitro laboratory research. Nothing here is a medicine, a supplement, a cosmetic or a therapeutic product, nothing here describes administration or application to humans or animals, and this guide is general information rather than medical, legal or research advice.

Frequently asked questions

What does SNAP-8 stand for?: The SNAP refers to SNAP-25, a protein involved in the machinery by which neurotransmitter is released at the neuromuscular junction, and the 8 refers to the peptide being eight residues long. The cosmetic rationale for the ingredient invokes that protein, which is where the name comes from. It is a reference to a proposed mechanism rather than a chemical description.
How does SNAP-8 relate to Argireline?: SNAP-8 is a longer version of it. Argireline is a trade name for acetyl hexapeptide-8, a six-residue cosmetic peptide; SNAP-8 extends that sequence to eight residues and appears in cosmetic ingredient listings as acetyl octapeptide-3. They come from the same line of cosmetic formulation development and invoke the same proposed mechanism, so they are routinely compared with one another in that industry\u2019s literature.
Is SNAP-8 a research peptide?: Not in the usual sense, and this is the most useful thing to understand about it. It was developed as an ingredient for topical cosmetic formulation, not as a laboratory tool compound, and the published work around it is predominantly cosmetic science rather than biomedical research. It is sold alongside research peptides for commercial reasons rather than because it belongs to the same category.
What is INCI naming?: The International Nomenclature of Cosmetic Ingredients, the standardised system used to list ingredients on cosmetic packaging. SNAP-8 appears in it as acetyl octapeptide-3. The existence of an INCI name is itself informative: it tells you the compound was brought to market as a cosmetic ingredient, which is a different regulatory pathway and a different evidence standard from either a medicine or a research reagent.
Is SNAP-8 a medicine?: No. It is not a medicine and holds no marketing authorisation as one. Cosmetic ingredients are regulated under cosmetics legislation rather than medicines legislation, and the evidence required for a cosmetic claim is substantially different from that required for a medicinal one. A compound with a cosmetic ingredient listing has not been through medicinal assessment.
Do you sell SNAP-8?: No. We do not stock it and there is no Certificate of Analysis for it in our library. It is covered here mainly to clarify the category confusion, since it is persistently listed as a research peptide when it is a cosmetic formulation ingredient.